SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-063325
Filing Date
2019-11-13
Accepted
2019-11-13 16:15:43
Documents
3
Period of Report
2019-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-22737_18k.htm 8-K 25686
2 EX-99.1 a19-22737_1ex99d1.htm EX-99.1 129528
3 GRAPHIC g227371mm01i001.jpg GRAPHIC 3130
  Complete submission text file 0001104659-19-063325.txt   160808
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 191214166
SIC: 2834 Pharmaceutical Preparations